When the FDA announced in mid-2025 that it would finally review the safety and legality of ingestible fluoride supplements for kids, the American Dental Association (ADA) rushed out a form letter and call to action urging dentists to flood the docket with copy-and-paste comments. That page has since vanished from the ADA’s website.

Normally, a removed page can be retrieved through the Wayback Machine, but in this case the archive shows the message:

Hrm. The Wayback Machine has not archived that URL.

(https://web.archive.org/web/20250716182035/https://www.ada.org/advocacy/legislative-action-center/fluoride-regulation)

Yet screenshots taken before the ADA scrubbed its site confirm that the page did exist, and a before-and-after comparison image appears on the left side of this article. In other words, the ADA’s call to action was published, promoted, and then deliberately erased from public view.

The missing page matters because it wasn’t neutral—it was loaded with boilerplate talking points portraying unapproved pediatric fluoride tablets and drops as “vital,” “clinically supported,” and unfairly threatened by “regulatory overreach.” In reality, almost every line misrepresents the science, the regulatory history, or the actual state of pediatric dentistry in 2025.

This was their call to action:

Call to Action:
The FDA has proposed taking pediatric ingestible fluoride supplement drug products off the market—a decision that would eliminate access to fluoride tablets and drops used to prevent tooth decay in children without adequate fluoride in their drinking water.
Dentists: Your voice is urgently needed.
Comment Deadline: July 16, 2025, 11:59 p.m. ET
Public Meeting: July 23, 2025, in person and online
These products are clinically supported and vital for vulnerable children, yet FDA is acting on inconclusive evidence and public pressure to eliminate them. The ADA is submitting official comments and strongly urges all members of the profession to speak out.

Here’s how you can help:

• Submit Your Comment: Fill out the form on this page to submit our prewritten language to comment on this regulation. Or please feel free to personalize your comment.

• Register for FDA’s Public Meeting: Attend in person or online on July 23 to hear perspectives and voice support (https://www.regulations.gov/docket/FDA-2025-N-1557).
  We need the profession to act now—before these fluoride supplements are lost to regulatory overreach.

Form Letter Sent on Behalf of the ADA:

As a licensed dentist and oral health provider, I write to express strong concern over FDA’s proposal to remove orally ingestible fluoride prescription drug products for children from the market.

Fluoride tablets and drops are an important tool for preventing tooth decay in children, especially those living in areas without access to fluoridated drinking water or who have limited ability to use topical fluoride. These products are supported by decades of clinical use and recommended by both the American Dental Association and the U.S. Preventive Services Task Force.

FDA has cited emerging safety concerns, but the majority of studies referenced involve fluoride levels significantly higher than those found in U.S. prescription products or lack methodological rigor. These concerns must be weighed against the well-established public health benefits of fluoride in preventing early childhood caries.

Importantly, this action would remove a valuable clinical option and limit parents’ ability to choose an evidence-based preventive measure for their children. While FDA and HHS officials have publicly emphasized the importance of respecting parental freedom in health care decisions, this proposal effectively eliminates a choice, despite its safety, affordability, and long-standing public health value.

I urge FDA to preserve access to prescription fluoride supplements and ensure that any regulatory decision is guided by high-quality scientific evidence and a commitment to preserving clinician and parent choice in pediatric care.